LOGO
LOGO

Gilead Sciences Inc. Bottom Line Rises In Q2, But Misses Estimates

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Gilead Sciences Inc. (GILD) revealed a profit for its second quarter that increased from last year but missed the Street estimates.

The company's bottom line totaled $1.614 billion, or $1.29 per share. This compares with $1.045 billion, or $0.83 per share, in last year's second quarter.

Analysts on average had expected the company to earn $1.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 5.4% to $6.954 billion from $6.599 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $1.614 Bln. vs. $1.045 Bln. last year.
-EPS (Q2): $1.29 vs. $0.83 last year.
-Revenue (Q2): $6.954 Bln vs. $6.599 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19